Could your generic medications get more expensive? Trump’s new tariff plan raises big questions

President Trump's proposal to impose a 100% tariff on imported generic drugs starting in 2028 and escalating to 200% in 2029 could significantly increase healthcare costs for Americans. This move aims to encourage drugmakers to relocate production to the U.S., but critics worry it might lead to higher prices and limited access to essential medications. The potential shift in pharmaceutical manufacturing could reshape the industry landscape, raising questions about affordability and accessibility of generic drugs in the future.